DOUGLASIN(102867-73-2)
- Name: DOUGLASIN
- Synonyms:Cyclodeca[b]furan-6-carboxylicacid,2,3,3a,4,5,8,9,11a-octahydro-5-hydroxy-10-methyl-3-methylene-4-[(2-methyl-1-oxo-2-butenyl)oxy]-2-oxo-,[3aS-[3aR*,4R*(E),5R*,6Z,10Z,11aS*]]-; Cyclodeca[b]furan-6-carboxylic acid,2,3,3a,4,5,8,9,11a-octahydro-5-hydroxy-10-methyl-3-methylene-4-[[(2E)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-,(3aS,4S,5S,6Z,10Z,11aR)- (9CI); Douglasin
- Molecular Formula:C20H24 O7
- Molecular Weight:376.4
- CAS Registry Number:102867-73-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.102867-73-2 DOUGLASIN
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 52158-06-2/N-({4-[(2,3-dichlorophenyl)amino]pyridin-3-yl}sulfonyl)propanamide
- 53220-35-2/1,3,5-Triazine-2,4-diamine,6-heptadecyl-N- (methoxymethyl)-
- 74039-39-7/1-(o-Chloro-alpha-methylbenzyl)pyrrolidine hydrochloride
- 98234-97-0/5,11-dihydro-6H-[1,3]dioxolo[4,5-h]imidazo[2,1-c][1,4]benzodiazepine
- 7061-36-1/5-[4-(hexyloxy)phenyl]-4-[hydroxy(pyridin-4-yl)methylidene]-1-(pyridin-3-ylmethyl)pyrrolidine-2,3-dione
- 98911-18-3/1-O-(phenylamino)-beta-D-glucopyranose
- 23852-98-4/methyl 4-{[(2E)-3-amino-2-(hydroxyimino)propyl](methyl)amino}benzoate
- 60999-40-8/1-azabicyclo[2.2.2]oct-2-yl(diphenyl)methanol
- 18002-32-9/4-amino-5-methyl-1-(tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
- 4484-20-2/Benzenesulphonic acid, compound with aniline (1:1)
- 54193-05-4/(1S,3S)-1,2-dimethyl-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid
- 2464-48-4/N,N-Dimethyltridecylammonium (2,4,5-trichlorophenoxy)acetate
- 39251-97-3/2-methoxyphenyl 2-furoate
- 76359-33-6/Agnolyt
- 107688-09-5/4-hydrazino-8-methoxy-5H-pyridazino[4,5-b]indole
- 15038-90-1/Benzene,1,2,3,5-tetrafluoro-4,6-bis[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenoxy]-
- 2346-64-7/2-(2,4-dimethylbenzoyl)-6-methylbenzoic acid
- 137203-80-6/docosyl-triethylenetetraminepentaacetic acid
- 33374-41-3/potassium prop-2-en-1-ol
- 102867-73-2/DOUGLASIN
- 93964-61-5/5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)[2-chloro-4-(dimethylamino)phenyl]methyl]-3-methylsalicylic acid
- 77275-70-8/(D-PRO2,D-PHE7,D-TRP9)-SUBSTANCE P
- 42048-72-6/1-(2-Amino-4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one
- 121181-46-2/Poly[oxy(ethyl-1,2-ethanediyl)],a-(4-dodecylphenyl)-w-hydroxy- (9CI)
- 27873-01-4/3,13-Dioxa-8-thia-2,14-disilapentadecane
- 160791-12-8/ardisicrenoside B
- 119415-22-4/Ethanol, 2-(2-aminoethyl)amino-, polymer with 1,3-diisocyanatomethylbenzene, .alpha.-hydro-.omega.-hydroxypolyoxy(methyl-1,2-ethanediyl) and 2,2-(1-methylethylidene)bis(4,1-phenyleneoxymethylene)bisoxirane
- 3027-01-8/Dibenzanilide
- 22131-40-4/3-({[(2,5-dioxo-1-phenylimidazolidin-4-yl)methyl]sulfanyl}methyl)-5-phenylimidazolidine-2,4-dione
- 68412-16-8/Octadecanamide, N-[2-[(2-hydroxyethyl)amino]ethyl]-, reaction products with urea